Monés, J., Srivastava, S. K., Jaffe, G. J., Tadayoni, R., Albini, T. A., Kaiser, P. K., . . . Heier, J. S. (2021). Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER. Ophthalmology (Rochester, Minn.), 128(7), 1050. https://doi.org/10.1016/j.ophtha.2020.11.011
Citace podle Chicago (17th ed.)Monés, Jordi, et al. "Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER." Ophthalmology (Rochester, Minn.) 128, no. 7 (2021): 1050. https://doi.org/10.1016/j.ophtha.2020.11.011.
Citace podle MLA (9th ed.)Monés, Jordi, et al. "Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER." Ophthalmology (Rochester, Minn.), vol. 128, no. 7, 2021, p. 1050, https://doi.org/10.1016/j.ophtha.2020.11.011.